Welcome to our dedicated page for Vita Coco Company SEC filings (Ticker: COCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
From the coconut farms of the Philippines to refrigerators across the U.S., Vita Coco turns raw coconuts into a global hydration franchise. That supply chain—and the social commitments behind it—surface in every SEC document. If you’ve searched for “Vita Coco SEC filings explained simply” or wondered how sustainability costs flow through the P&L, this page delivers the answers.
Here you will find the “Vita Coco annual report 10-K simplified” to track segment growth in The Americas, the “Vita Coco quarterly earnings report 10-Q filing” that reveals coconut cost inflation, and the “Vita Coco 8-K material events explained” whenever sourcing disruptions arise. Need to monitor management moves? Our dashboard surfaces “Vita Coco insider trading Form 4 transactions,” “Vita Coco Form 4 insider transactions real-time,” and “Vita Coco executive stock transactions Form 4” the moment they hit EDGAR. Corporate governance questions? Scan the “Vita Coco proxy statement executive compensation” to see how bonus targets align with carbon reduction goals. Each document includes concise summaries and real-time alerts.
Stock Titan’s AI distills every note into clear language, so “understanding Vita Coco SEC documents with AI” means you can jump straight to coconut-water revenue, cash flow, or sustainability metrics. Receive instant notifications, compare “Vita Coco earnings report filing analysis” quarter over quarter, and export numbers directly to your models. Save hours and make confident decisions with complete, up-to-date information.
IZEA Worldwide, Inc. (ticker: IZEA) filed a Form 4 on 1 July 2025 reporting that director Daniel R. Rua received 5,882 shares of common stock on 30 June 2025. The shares represent payment of Q2 2025 director fees valued at $15,000, calculated at the closing market price of $2.55 per share on the grant date. The restricted-stock award vested immediately and was acquired at $0 cash cost. Following the grant, Rua’s direct beneficial ownership increased to 85,259 shares. No derivative securities, sales, or additional transactions were disclosed, and the filing was made under Rule 10b5-1.
Form 4 Overview – Vita Coco Company, Inc. (COCO)
Chief Marketing Officer Jane Prior reported a paired option exercise and share sale dated 06/18/2025. She exercised 10,000 non-qualified stock options at an exercise price of $10.178 per share (transaction code “M”), immediately acquiring the same number of common shares. On the same day she sold 10,000 shares in the open market under a pre-arranged Rule 10b5-1 trading plan (transaction code “S”) at a weighted-average price of $35.116, within a range of $35.00–$35.33. After the transactions, Prior’s direct common-stock holding remains at 134,188 shares, unchanged on a net basis.
The filing also details Prior’s remaining derivative exposure: 169,479 vested and unvested options across eight grants with strike prices from $10.178 to $33.36 and expirations spanning 02/10/2030–03/04/2035. Of these, 63,750 options (strike $10.178) are now reduced by 10,000, reflecting the exercise. Vesting schedules for later grants extend through August 2032 and March 2035, ensuring a continued alignment of incentive compensation with long-term share performance.
Because the share sale offsets the option exercise, Prior’s economic exposure through common equity is unchanged; however, her derivative exposure decreased modestly. The use of a Rule 10b5-1 plan signals pre-planned execution, potentially mitigating signaling risk. No other insiders or directors were involved, and the filing lists no new option awards or share acquisitions beyond those described.
Form 144 filing highlights
On 18 June 2025, an affiliate of The Vita Coco Company, Inc. (NASDAQ: COCO) filed a Form 144 with the U.S. SEC. The notice states the filer intends to sell 10,000 common shares through Morgan Stanley Smith Barney LLC at an aggregate market value of $345,900, implying a reference price near $34.59 per share. The shares were acquired the same day via the exercise of stock options and are scheduled for sale on or about 18 June 2025 on the NASDAQ.
Transaction scale
The planned disposition equals roughly 0.018 % of Vita Coco’s 56,733,572 shares outstanding, signalling a de-minimis impact on the company’s float and no dilution, as the shares are already issued. The filer reported no other sales during the prior three-month period.
Regulatory context
Form 144 is a routine notice required when company insiders or affiliates intend to sell restricted or control securities under Rule 144. By signing, the filer affirms that no non-public material adverse information is known. No additional financial or operational data were provided in the document.
FAQ
What is the current stock price of Vita Coco Company (COCO)?
What is the market cap of Vita Coco Company (COCO)?
What does Vita Coco Company, Inc. specialize in?
How does Vita Coco generate revenue?
What makes Vita Coco different from its competitors?
What sustainability initiatives does Vita Coco undertake?
Where is Vita Coco's geographical presence strongest?
What are Vita Coco’s recent product innovations?
Is Vita Coco a sustainable company?
What is Vita Coco's mission as a public benefit corporation?
What industries does Vita Coco operate within?
What are Vita Coco’s primary revenue segments?
